Remaining Obstacles to the Success of Cancer Gene Therapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Earlier chapters in this book have described the technologies used for gene transfer and the manufacturing and regulatory requirements required to safely and legally exploit these technologies. This final chapter describes some of the obstacles to developing gene therapies from these early-phase clinical studies so that they can become licensed agents that are standards of practice as cancer therapeutics. Also outline are some of the remaining scientific limitations that will need to be addressed if gene therapies are to reach their broadest potential.

Original languageEnglish (US)
Title of host publicationCancer Gene Therapy by Viral and Non-viral Vectors
PublisherWiley
Pages151-156
Number of pages6
ISBN (Print)9781118501665, 9781118501627
DOIs
StatePublished - Mar 17 2014

Keywords

  • Cell therapy for cancer
  • Clinical trial design for biologicals
  • Drug development using biologicals
  • Gene therapy for cancer

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Remaining Obstacles to the Success of Cancer Gene Therapy'. Together they form a unique fingerprint.

Cite this